RALEIGH, N.C., June 15, 2020 /PRNewswire/ -- Contego Medical, Inc. today announced enrollment of the first patient in the PERFORMANCE II Trial evaluating the safety and effectiveness of the Neuroguard IEP® 3 in 1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection. The Neuroguard IEP System is designed to treat clinically significant carotid artery stenosis while improving procedural safety through the integration of stent, balloon and filter technology all in a single device. The first patient was treated at University of North Carolina Rex Hospital in Raleigh, North Carolina by James Zidar, M.D., FACC, FSCAI.